Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast‐enhanced MRI: A sensitivity and specificity study

The purpose of this study was to apply an empirical mathematical model (EMM) to kinetic data acquired under a clinical protocol to determine if the sensitivity and specificity can be improved compared with qualitative BI‐RADS descriptors of kinetics. 3D DCE‐MRI data from 100 patients with 34 benign and 79 malignant lesions were selected for review under an Institutional Review Board (IRB)‐approved protocol. The sensitivity and specificity of the delayed phase classification were 91% and 18%, respectively. The EMM was able to accurately fit these curves. There was a statistically significant difference between benign and malignant lesions for several model parameters: the uptake rate, initial slope, signal enhancement ratio, and curvature at the peak enhancement (at most P = 0.04). These results demonstrated that EMM analysis provided at least the diagnostic accuracy of the kinetic classifiers described in the BI‐RADS lexicon, and offered a few key advantages. It can be used to standardize data from institutions with different dynamic protocols and can provide a more objective classification with continuous variables so that thresholds can be set to achieve desired sensitivity and specificity. This suggests that the EMM may be useful for analysis of routine clinical data. Magn Reson Med 59:747–754, 2008. © 2008 Wiley‐Liss, Inc.

[1]  Claudia Weidensteiner,et al.  Quantitative dynamic contrast‐enhanced MRI in tumor‐bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T , 2006, Journal of magnetic resonance imaging : JMRI.

[2]  C. Metz,et al.  Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. , 1998, Statistics in medicine.

[3]  Mariko Goto,et al.  Diagnosis of breast tumors by contrast‐enhanced MR imaging: Comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features , 2007, Journal of magnetic resonance imaging : JMRI.

[4]  Cheryl Jorcyk,et al.  The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma , 2000, Oncogene.

[5]  Chiara Zuiani,et al.  Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. , 2006, AJR. American journal of roentgenology.

[6]  R. Schmidt,et al.  Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. , 2007, Radiology.

[7]  John Gosbee,et al.  ACR guidance document for safe MR practices: 2007. , 2007, AJR. American journal of roentgenology.

[8]  S. Harms The Use of Breast Magnetic Resonance Imaging in Ductal Carcinoma in Situ , 2005, The breast journal.

[9]  Wei Huang,et al.  Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. , 2007, Radiology.

[10]  A. Goode,et al.  The magnetization transfer characteristics of human breast tissues: an in vitro NMR study. , 1999, Physics in medicine and biology.

[11]  N. Hylton,et al.  Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. , 2006, Radiology.

[12]  Michael Brady,et al.  Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast , 2005, Medical Image Anal..

[13]  J. Hogg Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.

[14]  C. Claussen,et al.  Influence of age and menstrual cycle on mammography and MR imaging of the breast , 1997, Der Radiologe.

[15]  G. Newstead,et al.  Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation , 2008, Physics in medicine and biology.

[16]  B. Porter,et al.  Contrast-enhanced breast magnetic resonance imaging: the surgical perspective. , 2007, American journal of surgery.

[17]  C. Kuhl Concepts for differential diagnosis in breast MR imaging. , 2006, Magnetic resonance imaging clinics of North America.

[18]  Erica Markiewicz,et al.  High spectral and spatial resolution MRI of age‐related changes in murine prostate , 2008, Magnetic resonance in medicine.

[19]  Fiona J Gilbert,et al.  Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. , 2005, Radiology.

[20]  C. Catalano,et al.  Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. , 2005, Radiology.

[21]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .

[22]  P. Parizel,et al.  Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. , 2006, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

[23]  W. Kaiser,et al.  High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. , 2003, The British journal of radiology.

[24]  G Lutterbey,et al.  Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. , 1997, Radiology.

[25]  D. D. Billheimer,et al.  Repeatability of a reference region model for analysis of murine DCE‐MRI data at 7T , 2006, Journal of magnetic resonance imaging : JMRI.

[26]  Wendy B DeMartini,et al.  Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. , 2007, Radiology.

[27]  L. Tabár,et al.  Mammography and breast cancer: the new era , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[28]  L. Liberman Breast MR imaging in assessing extent of disease. , 2006, Magnetic resonance imaging clinics of North America.

[29]  C. Kuhl,et al.  Präoperatives Staging mit der Mamma-MRT: Pro und Kontra , 2008, Der Radiologe.

[30]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[31]  Edna Furman-Haran,et al.  Parametric analysis of breast MRI. , 2002, Journal of computer assisted tomography.

[32]  Peter Bult,et al.  The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. , 2006, American journal of surgery.

[33]  F. Kelcz,et al.  Magnetic resonance imaging of breast cancer angiogenesis: a review. , 2002, Journal of experimental & clinical cancer research : CR.

[34]  O Lucidarme,et al.  Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. , 1996, Journal of computer assisted tomography.

[35]  C. Quinn,et al.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast , 2002, Journal of clinical pathology.

[36]  G. Newstead MR imaging in the management of patients with breast cancer. , 2006, Seminars in ultrasound, CT, and MR.

[37]  F. Kelcz,et al.  Improvement in breast lesion characterization with dynamic contrast‐enhanced MRI using pharmacokinetic modeling and bookend T1 measurements , 2004, Magnetic resonance in medicine.

[38]  Andreas Makris,et al.  Early breast cancer , 2009, The Lancet.

[39]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[40]  Tibor Tot,et al.  Invasive breast cancer: correlation of dynamic MR features with prognostic factors , 2003, European Radiology.

[41]  Daniel F Chen,et al.  Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. , 2006, American journal of surgery.

[42]  G. Newstead,et al.  Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. , 2007, Magnetic resonance imaging.

[43]  M. Giger,et al.  Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. , 2006, Medical physics.

[44]  U. Fischer,et al.  International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions , 2001, European Radiology.

[45]  R. Elledge,et al.  Premalignant and In Situ Breast Disease: Biology and Clinical Implications , 2005, Annals of Internal Medicine.

[46]  Michael Brady,et al.  Analysis of dynamic MR breast images using a model of contrast enhancement , 1997, Medical Image Anal..

[47]  Stefan Vogt,et al.  DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents. , 2007, Journal of the American Chemical Society.

[48]  David Tritchler,et al.  Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.

[49]  Anthony J. Guidi,et al.  Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.

[50]  S. Heywang-Köbrunner,et al.  Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. , 1994, Radiology.

[51]  Simone Schrading,et al.  MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.

[52]  B. Szabó,et al.  Dynamic MR imaging of the breast: Analysis of kinetic and morphologic diagnostic criteria , 2003, Acta radiologica.

[53]  S. Jansen Detection and Evaluation of Early Breast Cancer via Magnetic Resonance Imaging: Studies of Mouse Models and Clinical Implementation , 2008 .

[54]  Hans H Schild,et al.  Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. , 2005, Radiology.

[55]  M. Oudkerk,et al.  Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. , 2003, AJR. American journal of roentgenology.

[56]  Bircan Erbas,et al.  The natural history of ductal carcinoma in situ of the breast: a review , 2006, Breast Cancer Research and Treatment.

[57]  Elizabeth A Morris,et al.  Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance Imaging , 2005, The breast journal.

[58]  Daniel F Chen,et al.  Magnetic resonance imaging captures the biology of ductal carcinoma in situ. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  E. Halpern,et al.  Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations. , 2005, Radiology.

[60]  Xiaobing Fan,et al.  Comparison and evaluation of mouse cardiac MRI acquired with open birdcage, single loop surface and volume birdcage coils , 2006, Physics in medicine and biology.

[61]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[62]  Frederick Kelcz,et al.  Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium‐enhanced MRI , 1996, Journal of magnetic resonance imaging : JMRI.

[63]  R. Warren,et al.  Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease? , 2005, Magnetic resonance imaging.

[64]  W H Perman,et al.  Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. , 1996, Magnetic resonance imaging.

[65]  B. Lai,et al.  Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[66]  Raymond C Boston,et al.  A modified logistic model to describe gadolinium kinetics in breast tumors. , 2004, Magnetic resonance imaging.

[67]  Laura Cortesi,et al.  Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. , 2007, Radiology.

[68]  S. Heywang-Köbrunner,et al.  In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging , 2000, Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine.

[69]  J O Barentsz,et al.  Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. , 1995, Radiology.

[70]  M. Kurosumi,et al.  Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography. , 2003, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[71]  S. Holm A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[72]  L D Buadu,et al.  Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. , 1996, Radiology.

[73]  Ying Lu,et al.  Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging , 2007, Magnetic resonance in medicine.

[74]  Women at high risk for breast cancer. , 1998, The American journal of nursing.

[75]  Stefan Vogt,et al.  MAPS : A set of software tools for analysis and visualization of 3D X-ray fluorescence data sets , 2003 .

[76]  J. L. Abraham,et al.  Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. , 2008, European journal of radiology.

[77]  G S Karczmar,et al.  A new method for imaging perfusion and contrast extraction fraction: Input functions derived from reference tissues , 1998, Journal of magnetic resonance imaging : JMRI.

[78]  Peter Aspelin,et al.  Dynamic MR Imaging Of The Breast , 2003 .

[79]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  L. Liberman,et al.  Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy. , 2007, AJR. American journal of roentgenology.

[81]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[82]  Nola Hylton,et al.  MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. , 2006, Magnetic resonance imaging clinics of North America.

[83]  C K Kuhl,et al.  Dynamic image interpretation of MRI of the breast , 2000, Journal of magnetic resonance imaging : JMRI.

[84]  Edna Schechtman,et al.  Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions , 2005, Cancer.

[85]  S G Orel MR imaging of the breast. , 2000, Radiologic clinics of North America.

[86]  M. Mehta,et al.  Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. , 2001, Cancer research.

[87]  C. Gatsonis,et al.  Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.

[88]  S. Heffelfinger,et al.  Angiogenic growth factors in preinvasive breast disease. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[89]  J L Evelhoch,et al.  Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.

[90]  L. Liberman,et al.  Ductal enhancement on MR imaging of the breast. , 2003, AJR. American journal of roentgenology.

[91]  Peter B Barker,et al.  Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. , 2003, Radiology.

[92]  M. Schnall,et al.  MR imaging of ductal carcinoma in situ. , 1997, Radiology.

[93]  S E Harms,et al.  Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging , 1996, Cancer.

[94]  H. Lehr,et al.  Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. , 2006, Radiology.

[95]  Laura Esserman,et al.  Contrast‐Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma , 1999, The breast journal.

[96]  Acta R Adiologica Analysis of kinetic and morphologic diagnostic criteria , 2003 .

[97]  Elizabeth A Morris,et al.  Nonpalpable mammographically occult invasive breast cancers detected by MRI. , 2006, AJR. American journal of roentgenology.

[98]  L. Liberman,et al.  Breast lesions detected on MR imaging: features and positive predictive value. , 2002, AJR. American journal of roentgenology.

[99]  Xiaobing Fan,et al.  New model for analysis of dynamic contrast‐enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors , 2004, Magnetic resonance in medicine.

[100]  Ying Lu,et al.  Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. , 2008, Radiology.

[101]  T. Frenzel,et al.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions , 2008, European Radiology.

[102]  D B Kopans,et al.  Benign and malignant breast lesions: differentiation with echo-planar MR imaging. , 1995, Radiology.